Why I would buy ResMed and these ASX growth shares

Here's why I would buy ResMed Inc. (ASX:RMD) and these ASX growth shares right now…

| More on:
nextdc share price

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

I'm a big fan of growth shares and feel very fortunate to have such a large number to choose from on the Australian share market.

Three ASX growth shares that I think would be top options for investors are listed below. Here's why I think they could generate outsized returns for investors over the next decade:

IDP Education Ltd (ASX: IEL)

The first growth share to look at is IDP Education. It is a leading provider of international student placement services and English language testing services. Given the closure of borders globally, IDP Education has been impacted negatively by the pandemic. However, with its shares down almost 50% from their 52-week high, I'm confident this is more than priced in now. In light of this, I think now could be an opportune time to invest. Especially given its strong balance sheet and its very positive long term growth outlook.

NEXTDC Ltd (ASX: NXT)

Another growth share to consider buying is NEXTDC. Unlike IDP Education, NEXTDC has been a big winner from the pandemic thanks to the accelerating shift to the cloud. The good news is that there's still a long way to go for the cloud computing boom. According to global technology research firm Gartner, it has forecast that 80% of all organisations will shift their workloads to third-party data centres by 2025. Overall, I expect this to lead to increasing demand for its innovative data centre outsourcing solutions over the next decade.

ResMed Inc. (ASX: RMD)

A final ASX growth share to consider buying is ResMed. I'm confident the medical device company can continue its solid growth over the next decade thanks to its focus on the sleep treatment market. This lucrative market is growing quickly due to the proliferation of obstructive sleep apnoea and other sleep disorders. And given the quality of its products and software, I believe it is well-positioned to capture a growing slice of this market.

James Mickleboro owns shares of NEXTDC Limited. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Idp Education Pty Ltd. The Motley Fool Australia has recommended ResMed Inc. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

a man in a business suit points his finger amid a digitised map of the globe suspended in the air in front of him, complete with graphs, digital code and glyphs to indicate digital assets.
Investing Strategies

Future focus: How to diversify your portfolio with ASX AI ETFs

Looking for a simple and effective way to capitalise on the growth of AI technologies across global markets?

Read more »

chart showing an increasing share price
Growth Shares

Buy these excellent ASX growth shares for 15% to 20% returns

Analysts think big returns could be on the cards for owners of these shares.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Growth Shares

These ASX 200 growth shares could rise 12% to 30%

Analysts think big returns could be on offer from these shares.

Read more »

Man in an office celebrates at he crosses a finish line before his colleagues.
Growth Shares

Hoping to beat the ASX 200? I'd consider buying these 3 ASX shares

Analysts think these shares can outperform the market.

Read more »

a happy investor with a wide smile points to a graph that shows an upward trending share price
Growth Shares

5 top ASX growth shares to buy in April

Analysts think growth investors should be buying these shares.

Read more »

A young woman holds her hand to her mouth in surprise as she reads something on her laptop.
Growth Shares

These mid-cap ASX shares could rise 20% to 50%

Goldman Sachs is tipping these stocks as buys.

Read more »

A happy boy with his dad dabs like a hero while his father checks his phone.
Growth Shares

2 ASX growth shares that could turn $1,000 into $10,000 by 2034

I think these two stocks have a shot at being 10-baggers.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Growth Shares

These top ASX 200 growth shares can rise 10% to 50%

Analysts see major upside ahead for these buy-rated shares.

Read more »